In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.
Gabrielle Ientile, Assistant Editor
Convalescent plasma, hydroxychloroquine, and remdesivir among the potential COVID-19 treatment pathways being pursued.
Pediatricians stress the importance of understanding the effects of COVID-19 on children.
Increases in PrEP coverage were associated with reductions in HIV infections, a new study found.
Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.
A study identified significant similarities between SARS-CoV and SARS-CoV-2.
Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.
Telehealth advancements in response to COVID-19 reveal the importance of digital health delivery during outbreaks.
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.
Sebela Pharmaceuticals has announced the FDA approval of lactitol (Pizensy), an oral solution for treating chronic idiopathic constipation (CIC) in adults, according to their press release.